Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

Recruiting now · Not applicable

Conditions studied: Atopic Dermatitis, Eczema

In brief

Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.

Key facts

Study ID

NCT07746427

Run by

Weill Medical College of Cornell University

People needed

40

Starts

2026-08-15

Expected to finish

2028-07-01

Last updated by the study team

2026-08-07

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adolescents age 12-17 years.
• Atopic dermatitis refractory to standard topical treatment including topical steroids or topical calcineurin inhibitors.
• Moderate to severe atopic dermatitis via PO-SCORAD score on enrollment.

You may not qualify if…

• Started on a biologic agent (i.e. dupxient) within the past 3 months.
• Mild atopic dermatitis via PO-SCORAD score on enrollment.

Where it is running

• Columbia University Irving Medical Center — New York, New York, United States (enrolling)
• Weill Cornell Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.